Revvity, Inc.
$93.89
▼
-0.4%
2026-04-22 10:12:13
www.revvity.com
NYQ: RVTY
Explore Revvity, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$10.54 B
Current Price
$93.89
52W High / Low
$118.3 / $81.36
Stock P/E
28.42
Book Value
$64.57
Dividend Yield
0.3%
ROCE
3.29%
ROE
3.22%
Face Value
—
EPS
$4.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
11,000
Beta
1.13
Debt / Equity
46.87
Current Ratio
1.68
Quick Ratio
1.4
Forward P/E
14.96
Price / Sales
3.51
Enterprise Value
$12.52 B
EV / EBITDA
14.88
EV / Revenue
4.38
Rating
Buy
Target Price
$118.27
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Labcorp Holdings Inc. | $271.17 | 25.93 | $22.36 B | 1.07% | 9.74% | 10.51% | $293.72 / $209.38 | $104.86 |
| 2. | iSpecimen Inc. | $0.13 | — | $4.05 M | — | -355.55% | -3.28% | $3.18 / $0.1 | $0.31 |
| 3. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 4. | Check-Cap Ltd. | $1.9 | — | $13.56 M | — | 659.83% | -1.3% | $3.92 / $0.59 | $0.64 |
| 5. | OPKO Health, Inc. | $1.22 | — | $926.06 M | — | -12.27% | -17.14% | $1.6 / $1.09 | $1.67 |
| 6. | Medpace Holdings, Inc. | $513.23 | 33.75 | $14.67 B | — | 84.68% | 70.23% | $628.92 / $250.05 | $16.18 |
| 7. | CareDx, Inc. | $21.29 | — | $1.11 B | — | -7.75% | -6.27% | $23.24 / $10.96 | $5.95 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 772.06 M | 698.95 M | 720.28 M | 664.76 M | 729.37 M | — |
| Operating Profit | 111.75 M | 81.9 M | 89.06 M | 72.23 M | 124.53 M | — |
| Net Profit | 98.36 M | 46.65 M | 53.95 M | 42.24 M | 94.64 M | — |
| EPS in Rs | 0.88 | 0.42 | 0.48 | 0.38 | 0.85 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.86 B | 2.76 B | 2.75 B | 3.31 B |
| Operating Profit | 356.63 M | 346.74 M | 300.56 M | 742.7 M |
| Net Profit | 241.2 M | 270.38 M | 693.09 M | 569.18 M |
| EPS in Rs | 2.16 | 2.42 | 6.2 | 5.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 12.17 B | 12.39 B | 13.56 B | 14.13 B |
| Total Liabilities | 4.92 B | 4.73 B | 5.69 B | 6.75 B |
| Equity | 7.25 B | 7.67 B | 7.87 B | 7.38 B |
| Current Assets | 2.24 B | 2.35 B | 3 B | 3.29 B |
| Current Liabilities | 1.33 B | 653.1 M | 1.45 B | 1.54 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 582.93 M | 628.3 M | 91.27 M | 679.81 M |
| Investing CF | -17.35 M | 776.16 M | 1.31 B | -132.85 M |
| Financing CF | -857.52 M | -1.13 B | -947.12 M | -661.8 M |
| Free CF | 509.41 M | 541.65 M | 9.9 M | 594.18 M |
| Capex | -73.52 M | -86.65 M | -81.37 M | -85.63 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.16% | -16.95% | — | — |
| Earnings Growth % | -60.99% | 21.77% | — | — |
| Profit Margin % | 9.81% | 25.2% | 17.19% | — |
| Operating Margin % | 12.59% | 10.93% | 22.43% | — |
| Gross Margin % | 55.81% | 55.98% | 60.08% | — |
| EBITDA Margin % | 30.5% | 25.94% | 35.71% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-01-16 | $0.07 |
| 2025-10-17 | $0.07 |
| 2025-07-18 | $0.07 |
| 2025-04-17 | $0.07 |
| 2025-01-17 | $0.07 |
Stock Splits
No stock split history available.